There has been a recent shortage of a number of menopausal hormone therapy (MHT) preparations and some of these have now been or soon will be resolved:

Oral MHT

Femoston 1/10 – resolved

Duavive – supply due to be resolved by end January 2022

Angeliq - resolved 

Transdermal

Climara – resolved

Estradot 100 – resolved

Estradot 75 – supply due to be resolved by the early April

Estradot 50 – supply due to be resolved by the early February

Estradot 37.5 – supply due to be resolved by early April

Estradot 25 – resolved

Estalis Conti - resolved

Estalis Sequi 50/140 –supply due to be resolved by mid February

Estalis Sequi 50/250 –supply due to be resolved by mid February

Estraderm MX 50 – supply due to be resolved by end of April

Estraderm MX 100 - supply due to be resolved by end of April 

Estrogel/Estrogel Pro – resolved

Please note that dates for supply have been sourced from either the pharmaceutical distributor or the TGA website and may change at any time.

Want to Know more about Early Menopause?

Early menopause changes you. You physically have changed. You emotionally change. You psychologically change.

Join a panel of leading experts and women with lived experience of early menopause with an opportunity to ask your questions.

Click on links below to register:

19 October 2020, 2:30 pm – Spontaneous Early Menopause

16 November 2020, 10:00 am – Early Menopause associated with gynecological cancer

30 November 2020, 10:30 am - Early Menopause associated with breast cancer

Even if you can’t join live, register now and we’ll send you the recorded webcast to watch at your convenience.

For further information please email: This email address is being protected from spambots. You need JavaScript enabled to view it. 

Early Menopause Webinars – 3 Part Series Flyer235.64 KB